Genetic analysis of effort discounting in C. elegans
线虫努力折扣的遗传分析
基本信息
- 批准号:10244629
- 负责人:
- 金额:$ 21.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2023-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAnimal ModelAwardBacteriaBehaviorBiological AssayBiological MarkersCaenorhabditis elegansCandidate Disease GeneCharacteristicsCollectionConsumptionCosts and BenefitsCoupledDecision MakingDiagnosisDiagnosticDiseaseDopamineEtiologyExhibitsFailureFelis catusFoodFood PreferencesFosteringFruitFutureGenesGeneticGenetic PolymorphismGenetic ScreeningGenotypeHeritabilityHourHumanHuman GenomeImpulsivityIndividualIngestionLawsLearningLinkLiquid substanceLogicMammalsMapsMeasuresMethodsMicrofluidicsModelingNatureNematodaNeurotransmittersOrganismOrthologous GeneOutcomePathway interactionsPersonsPharmacologyPhenotypePrevention programQuantitative GeneticsResearchResearch PersonnelResourcesRewardsSample SizeSerotoninSignal TransductionSiteSocietiesSourceStreamSubstance abuse problemSuspensionsSystemTestingTimeTranslatingValidationVariantViscosityaddictionbasebehavioral economicsbehavioral studybiobehaviorcomparativecompare effectivenesscostcost effectivedensitydiscountingendophenotypeexperimental studyfeedinggene discoverygenetic analysisgenetic associationgenetic variantgenome sequencinggenome wide association studyhigh riskhigh throughput screeningindividualized medicineindividualized preventioninnovationlearning abilityoptogeneticsphysical propertypredictive modelingresponsescreeningtraittreatment programward
项目摘要
PROJECT SUMMARY/ABSTRACT
Substance abuse causes immeasurable personal suffering and exacts a devastating toll on society. Most ad-
dictive disorders have a significant genetic basis. Thus, a deeper understanding of the genetic pathways in-
volved in addiction, coupled with genome sequencing, could yield individualized treatment and prevention pro-
grams tailored to a person's addiction liability genotype.
Unfortunately, substance abuse disorder (SUD) is an extremely broad diagnosis that likely subsumes a multi-
tude of deficits. It has proved difficult to link variants of individual genes to such a broad disorder, even when
using powerful approaches such as human genome-wide association (GWA) mapping. In response, research-
ers are now shifting their focus to bio-behavioral markers of substance abuse, including several forms of impul-
sivity, which are simpler to identify, yet well correlated with substance abuse, and likewise heritable.
Initial GWA mappings of impulsivity genes with large effects, though successful, indicate that the cost of the
next step – of finding the many genes with small but nevertheless essential effects – may be prohibitive. More-
over, there remains the problem of functional analysis, translating lists of mapped genes into predictive models
of how they interact to produce the disorder. Both concerns could be addressed if bio-behavioral markers of
SUD could be demonstrated in genetically tractable, small-animal models, which are amenable to inexpensive
GWA mappings and functional genetic analysis. This project seeks to establish a model of addiction related
impulsivity in one such a model, the nematode worm C. elegans.
The research focuses on a form of impulsivity called effort discounting, the tendency to choose low-effort, low-
value rewards over high-effort, high-value rewards. We have shown that C. elegans assigns values to food re-
wards based on their inherent quality and the physical costs of ingesting them. Capitalizing on this, we will opti-
mize methods of increasing the physical costs of specific foods in high-throughput assays. Then, we will use
these assays to ascertain whether the strength of signaling by the neurotransmitter dopamine is correlated with
selection of high-effort options, as it is in mammalian models. Finally, we will estimate the heritability of effort
discounting in C. elegans by quantifying this phenotype in a small collection of wild-caught, genetically diver-
gent C. elegans strains. If successful, the research will establish a rapid, cost-effective method for accelerating
gene discovery related to substance abuse disorders.
项目摘要/摘要
滥用药物会造成不可估量的个人苦难,并严重对社会造成毁灭性的损失。最广告
命令障碍具有明显的遗传基础。这是对遗传途径的更深入的理解
成瘾,再加上基因组测序,可以产生个性化的治疗和预防
根据一个人的成瘾责任基因型量身定制的克。
不幸的是,药物滥用障碍(SUD)是一种极为广泛的诊断,可能归因于多种
缺陷的tude。事实证明,即使
使用强大的方法,例如人类全基因组关联(GWA)映射。作为回应,研究 -
现在,ERS正在将重点转移到滥用毒品的生物行为标记上,其中包括几种形式的冲动
更简单的识别,但与滥用毒品相关,同样可以遗传。
最初的GWA映射具有巨大影响的冲动基因,尽管成功,这表明
可能会禁止下一步 - 找到许多具有小但基本影响的基因。更多的-
结束时,仍然存在功能分析的问题,将映射基因的列表转化为预测模型
它们如何相互作用以产生疾病。如果生物行为标记
SUD可以在一般可拖动的小动物模型中证明,这些模型适合便宜
GWA映射和功能遗传分析。该项目旨在建立与成瘾相关的模型
在这样一个模型中,冲动性是线虫蠕虫秀丽隐杆线虫。
该研究重点是一种冲动性的形式,称为努力打折,选择低及低 - 低 -
价值奖励高高,高价值奖励。我们已经表明,秀丽隐杆线虫将价值分配给食物重新 -
病房基于其继承的质量和摄取其的物理成本。利用这一点,我们将选择
在高通量测定中增加特定食物的物理成本的方法。然后,我们将使用
这些测定法确定神经递质多巴胺的信号强度是否与
在哺乳动物模型中,选择高贵的选项。最后,我们将估计努力的遗传力
通过在一小部分野生捕获的,基因脱位的量子中量化这种表型,在秀丽隐杆线虫中打折 -
绅士秀丽隐杆线虫菌株。如果成功,该研究将建立一种加速的快速,成本效益的方法
基因发现与药物滥用障碍有关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SHAWN R LOCKERY其他文献
SHAWN R LOCKERY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SHAWN R LOCKERY', 18)}}的其他基金
Genetic analysis of effort discounting in C. elegans
线虫努力折扣的遗传分析
- 批准号:
10363756 - 财政年份:2021
- 资助金额:
$ 21.62万 - 项目类别:
Neurogenetic analysis of value-based decision making
基于价值的决策的神经遗传学分析
- 批准号:
10205097 - 财政年份:2018
- 资助金额:
$ 21.62万 - 项目类别:
Neurogenetic analysis of value-based decision making
基于价值的决策的神经遗传学分析
- 批准号:
9769082 - 财政年份:2018
- 资助金额:
$ 21.62万 - 项目类别:
Neurogenetic analysis of value-based decision making
基于价值的决策的神经遗传学分析
- 批准号:
9227202 - 财政年份:2016
- 资助金额:
$ 21.62万 - 项目类别:
Microfluidic screening devices for health-span extending drugs
用于延长健康寿命药物的微流体筛选装置
- 批准号:
8647832 - 财政年份:2014
- 资助金额:
$ 21.62万 - 项目类别:
Microfluidic devices for high-throughput anthelmintic screens
用于高通量驱虫筛选的微流体装置
- 批准号:
7830469 - 财政年份:2009
- 资助金额:
$ 21.62万 - 项目类别:
Microfluidic devices for high-throughput anthelmintic screens
用于高通量驱虫筛选的微流体装置
- 批准号:
7937008 - 财政年份:2009
- 资助金额:
$ 21.62万 - 项目类别:
Imaging neuronal activity with voltage-sensitive Green Fluorescent Protein
使用电压敏感绿色荧光蛋白对神经元活动进行成像
- 批准号:
7281607 - 财政年份:2003
- 资助金额:
$ 21.62万 - 项目类别:
Imaging neuronal activity with voltage-sensitive GFP
使用电压敏感 GFP 成像神经元活动
- 批准号:
6611666 - 财政年份:2003
- 资助金额:
$ 21.62万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
利用碱基编辑器治疗肥厚型心肌病的动物模型研究
- 批准号:82300396
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
利用小型猪模型评价动脉粥样硬化易感基因的作用
- 批准号:32370568
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
丁苯酞通过调节细胞异常自噬和凋亡来延缓脊髓性肌萎缩症动物模型脊髓运动神经元的丢失
- 批准号:82360332
- 批准年份:2023
- 资助金额:31.00 万元
- 项目类别:地区科学基金项目
APOBEC3A驱动膀胱癌发生发展的动物模型及其机制研究
- 批准号:82303057
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
The Role of Glycosyl Ceramides in Heart Failure and Recovery
糖基神经酰胺在心力衰竭和恢复中的作用
- 批准号:
10644874 - 财政年份:2023
- 资助金额:
$ 21.62万 - 项目类别:
Milk fat globule-EGF factor 8 and hepatocyte apoptosis-induced liver wound healing response
乳脂肪球-EGF因子8与肝细胞凋亡诱导的肝脏创面愈合反应
- 批准号:
10585802 - 财政年份:2023
- 资助金额:
$ 21.62万 - 项目类别:
Fecal Microbiota Transfer Attenuates Aged Gut Dysbiosis and Functional Deficits after Traumatic Brain Injury
粪便微生物群转移可减轻老年肠道菌群失调和脑外伤后的功能缺陷
- 批准号:
10573109 - 财政年份:2023
- 资助金额:
$ 21.62万 - 项目类别:
Mentoring Emerging Researchers at CHLA (MERCH-LA)
指导 CHLA (MERCH-LA) 的新兴研究人员
- 批准号:
10797938 - 财政年份:2023
- 资助金额:
$ 21.62万 - 项目类别:
CNS Effects of Alcohol: Cellular Neurobiology
酒精对中枢神经系统的影响:细胞神经生物学
- 批准号:
10834659 - 财政年份:2023
- 资助金额:
$ 21.62万 - 项目类别: